Smithfield Trust CO Abbott Laboratories Transaction History

Smithfield Trust CO

  • $2.01 Billion
  • Q4 2024

A detailed history of Smithfield Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Smithfield Trust CO holds 30,968 shares of ABT stock, worth $3.99 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
30,968
Previous 30,968 -0.0%
Holding current value
$3.99 Million
Previous $3.53 Million 0.82%
% of portfolio
0.17%
Previous 0.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$100.07 - $118.13 $3,302 - $3,898
33 Added 0.11%
30,968 $3.53 Million
Q2 2024

Jul 31, 2024
SELL
$100.73 - $112.44 $5,842 - $6,521
-58 Reduced 0.19%
30,935 $3.21 Million
Q1 2024

May 07, 2024
SELL
$109.52 - $120.96 $43,698 - $48,263
-399 Reduced 1.27%
30,993 $3.52 Million
Q4 2023

Feb 07, 2024
SELL
$90.19 - $110.4 $13,438 - $16,449
-149 Reduced 0.47%
31,392 $3.46 Million
Q3 2023

Nov 06, 2023
SELL
$95.53 - $114.62 $172,813 - $207,347
-1,809 Reduced 5.42%
31,541 $3.05 Million
Q2 2023

Aug 08, 2023
BUY
$100.78 - $112.29 $15,217 - $16,955
151 Added 0.45%
33,350 $3.63 Million
Q1 2023

May 11, 2023
BUY
$96.86 - $114.01 $74,001 - $87,103
764 Added 2.36%
33,199 $3.36 Million
Q4 2022

Feb 13, 2023
BUY
$95.06 - $111.52 $6,464 - $7,583
68 Added 0.21%
32,435 $3.56 Million
Q3 2022

Nov 14, 2022
SELL
$96.76 - $112.03 $19,932 - $23,078
-206 Reduced 0.63%
32,367 $3.13 Million
Q2 2022

Aug 11, 2022
BUY
$102.07 - $123.37 $2,449 - $2,960
24 Added 0.07%
32,573 $3.53 Million
Q1 2022

May 16, 2022
SELL
$114.02 - $139.04 $82,094 - $100,108
-720 Reduced 2.16%
32,549 $3.85 Million
Q4 2021

Feb 14, 2022
SELL
$115.53 - $141.46 $24,376 - $29,848
-211 Reduced 0.63%
33,269 $4.68 Million
Q3 2021

Nov 12, 2021
BUY
$116.66 - $129.06 $108,027 - $119,509
926 Added 2.84%
33,480 $3.96 Million
Q2 2021

Jul 26, 2021
SELL
$105.79 - $124.53 $184,709 - $217,429
-1,746 Reduced 5.09%
32,554 $3.77 Million
Q1 2021

May 14, 2021
SELL
$108.84 - $128.23 $21,114 - $24,876
-194 Reduced 0.56%
34,300 $4.11 Million
Q4 2020

Feb 12, 2021
BUY
$105.0 - $114.42 $17,325 - $18,879
165 Added 0.48%
34,494 $3.78 Million
Q3 2020

Nov 16, 2020
BUY
$91.64 - $111.29 $11,913 - $14,467
130 Added 0.38%
34,329 $3.74 Million
Q2 2020

Aug 14, 2020
BUY
$76.57 - $98.0 $239,740 - $306,838
3,131 Added 10.08%
34,199 $3.13 Million
Q1 2020

May 05, 2020
SELL
$62.82 - $91.86 $29,651 - $43,357
-472 Reduced 1.5%
31,068 $2.45 Million
Q4 2019

Feb 13, 2020
SELL
$78.51 - $87.4 $44,907 - $49,992
-572 Reduced 1.78%
31,540 $2.74 Million
Q3 2019

Oct 30, 2019
SELL
$81.84 - $88.74 $11,866 - $12,867
-145 Reduced 0.45%
32,112 $2.69 Million
Q2 2019

Aug 06, 2019
BUY
$72.88 - $85.0 $12,972 - $15,130
178 Added 0.55%
32,257 $2.71 Million
Q1 2019

Apr 30, 2019
SELL
$66.22 - $80.06 $58,604 - $70,853
-885 Reduced 2.68%
32,079 $2.56 Million
Q4 2018

Feb 04, 2019
SELL
$65.56 - $74.27 $19,668 - $22,281
-300 Reduced 0.9%
32,964 $2.39 Million
Q3 2018

Nov 05, 2018
SELL
$60.81 - $73.36 $17,026 - $20,540
-280 Reduced 0.83%
33,264 $2.44 Million
Q2 2018

Jul 16, 2018
BUY
$57.57 - $63.54 $484,221 - $534,434
8,411 Added 33.47%
33,544 $2.05 Million
Q1 2018

May 10, 2018
SELL
$56.27 - $63.62 $92,958 - $105,100
-1,652 Reduced 6.17%
25,133 $1.51 Million
Q4 2017

Feb 02, 2018
BUY
$53.68 - $57.47 $623,171 - $667,169
11,609 Added 76.5%
26,785 $1.53 Million
Q3 2017

Nov 03, 2017
BUY
$48.06 - $53.64 $729,358 - $814,040
15,176
15,176 $810,000

Others Institutions Holding ABT

# of Institutions
3,440
Shares Held
1.34B
Call Options Held
10.5M
Put Options Held
8.72M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $226B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Smithfield Trust CO Portfolio

Follow Smithfield Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithfield Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Smithfield Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email